Biologics

Aesculap, Inc. Launches Lyoplant® Onlay Dura Substitute

A biological, collagen based, absorbable dura substitute consisting of a bi-layer membrane; designed to provide superior protection and ease of use.

Aesculap, Inc. is pleased to announce the availability of Lyoplant® Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary.

Reliable

  • Helps protect against CSF leakage
  • Excellent resorption rates
  • Superior tensile strength,10x stronger than Suturable DuraGen*
  • Strong biocompatibility

Simple

  • Familiar use
  • Time-saving onlay application
  • Convenient handling
  • Superior suture pull-out, 10x stronger than Suturable DuraGen*

Versatile

  • Multi-use: Onlay or Suturable
  • 40% thinner than Suturable DuraGen*
  • Excellent elasticity and flexibility
  • Helps prevent cortical adhesion

Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater. To learn more about Lyoplant Onlay, visit aesculapusa.com/products/neurosurgery/dura-substitutes or contact your local Aesculap Sales Representative.

*Biomechanical data is on file at Aesculap, Inc. All testing results are based on averages. Tensile strength and suture retention testing were performed in a rehydrated state.

Amy Burkey
Senior Project Manager – Corporate Communications
Aesculap, Inc.
610.984.9245
amy.burkey@aesculap.com

About Aesculap, Inc.

Aesculap, Inc., a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients’ lives. For more information, call 800-282-9000 or visit aesculapusa.com .

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close